KRAS G12C inhibitor 16
Product Specifications
UNSPSC Description
KRAS G12C inhibitor 16 is a potent KRAS G12C inhibitor extracted from patent WO2019110751A1, compound 39, has an IC50 of 97 nM[1].
Target Antigen
Ras
Type
Reference compound
Related Pathways
GPCR/G Protein;MAPK/ERK Pathway
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/kras-g12c-inhibitor-16.html
Solubility
10 mM in DMSO
Smiles
OC1=C(C2=C(C)C(N=CC3=C4N5[C@H](CN(C(C=C)=O)CC5)CO3)=C4C=C2Cl)C(F)=CC=C1
Molecular Weight
453.89
References & Citations
[1]Jason Grant Kettle, et al. Tetracyclic compounds as inhibitors of g12c mutant ras protein, for use as anti-cancer agents. WO2019110751A1.
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-125874/KRAS-G12C-inhibitor-16-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-125874/
Clinical Information
No Development Reported
CAS Number
2349392-79-4
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
Rat Charged multivesicular body protein 4b (CHMP4B) ELISA Kit
Rat Charged multivesicular body protein 4b (CHMP4B) ELISA Kit
Rat Charged multivesicular body protein 4b (CHMP4B) ELISA Kit
Rat Charged multivesicular body protein 4b (CHMP4B) ELISA Kit
